Suppr超能文献

儿童急性肾损伤:普通儿科医生关注的重点

Acute Kidney Injury in Children: A Focus for the General Pediatrician.

作者信息

Rivetti Giulio, Gizzone Pietro, Petrone Delfina, Di Sessa Anna, Miraglia Del Giudice Emanuele, Guarino Stefano, Marzuillo Pierluigi

机构信息

Department of Woman, Child and of General and Specialized Surgery, Università degli Studi della Campania "Luigi Vanvitelli", Via Luigi de Crecchio 2, 80138 Naples, Italy.

出版信息

Children (Basel). 2024 Aug 16;11(8):1004. doi: 10.3390/children11081004.

Abstract

Acute kidney injury (AKI) presents significant challenges in pediatric care, often remaining underrecognized. This paper provides an overview of pediatric AKI, highlighting its epidemiology, pathophysiology, diagnosis, predisposing conditions, and treatment. AKI in children stems from diverse causes, including renal tubular damage, vasoconstriction, and inflammation. Diagnosis relies on traditional markers such as serum creatinine and urine output, alongside emerging biomarkers such as Cystatin C, NGAL, KIM-1, IL-18, TIMP-2 and IGFBP7, urinary calprotectin, URBP4, L-FABP, and clusterin. Various pediatric conditions predispose to AKI, including type 1 diabetes, pneumonia, bronchiolitis, appendicitis, gastroenteritis, COVID-19, multisystem inflammatory syndrome, sickle cell disease, and malignancies. Treatment entails supportive care with fluid management and, in severe cases, renal replacement therapy. Timely recognition and management are essential to mitigating adverse outcomes. Enhanced awareness and integration of novel biomarkers could improve pediatric AKI care, warranting further research for better diagnosis and management.

摘要

急性肾损伤(AKI)在儿科护理中面临重大挑战,往往未得到充分认识。本文概述了儿童急性肾损伤,重点介绍了其流行病学、病理生理学、诊断、诱发因素和治疗方法。儿童急性肾损伤的病因多种多样,包括肾小管损伤、血管收缩和炎症。诊断依赖于血清肌酐和尿量等传统指标,以及胱抑素C、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、肾损伤分子-1(KIM-1)、白细胞介素-18(IL-18)、金属蛋白酶组织抑制因子-2(TIMP-2)和胰岛素样生长因子结合蛋白7(IGFBP7)、尿钙卫蛋白、URBP4、肝型脂肪酸结合蛋白(L-FABP)和簇集素等新兴生物标志物。多种儿科疾病易引发急性肾损伤,包括1型糖尿病、肺炎、支气管炎、阑尾炎、肠胃炎、2019冠状病毒病(COVID-19)、多系统炎症综合征、镰状细胞病和恶性肿瘤。治疗需要通过液体管理进行支持性护理,在严重情况下需要进行肾脏替代治疗。及时识别和管理对于减轻不良后果至关重要。提高对新型生物标志物的认识并将其整合应用,可能会改善儿童急性肾损伤的护理,因此有必要进行进一步研究以实现更好的诊断和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1fd/11352805/f35c87fd7713/children-11-01004-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验